Cigarette smoking in Parkinson's disease: influence on disease progression.
about
Cytochrome P450-mediated drug metabolism in the brainSmoking duration, intensity, and risk of Parkinson diseaseCytochrome P450 mediates dopamine formation in the brain in vivo.History of smoking and olfaction in Parkinson's disease.α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.Cytochrome P450 enzymes in the brain: emerging evidence of biological significanceMortality and Its Risk Factors in Patients with Rapid Eye Movement Sleep Behavior Disorder.Cytochrome P450 2D6 enzyme neuroprotects against 1-methyl-4-phenylpyridinium toxicity in SH-SY5Y neuronal cells.Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment.Targeting nicotinic receptors for Parkinson's disease therapy.Can nicotine be used medicinally in Parkinson's disease?Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts.Smoking history is associated to cognitive impairment in Parkinson's disease.Investigating the receptor-independent neuroprotective mechanisms of nicotine in mitochondria.Does smoking impact dopamine neuronal loss in de novo Parkinson disease?Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.Parkinson's disease and the risk of cerebrovascular pathology.Smoking cessation for the neurologic patient.Hypersexuality and pathological gambling in Parkinson's disease: A cross-sectional case-control study.Survival of Parkinson's disease patients in a large prospective cohort of male health professionals.
P2860
Q28397217-329C4B84-A7B7-45D8-8C6E-AD22D61DD292Q33720760-336FACD3-7EFA-45F7-BCFE-31CF2635ACA1Q33925984-BAE29DE2-B40A-4449-AFAC-B120E53676A7Q33934900-D63DDA2E-70FB-40A7-9CC2-E8E295F19168Q35264378-A8D82467-AF95-472F-B389-671317A2F437Q35570962-83889973-A849-420A-8DFF-E88B9C1E02C5Q37095501-C6701CEE-F4EA-412F-8E5D-807C0AB61B0AQ37603882-843ED352-0752-477E-A6F1-D93ECF622F9FQ37603891-18E366C3-33CF-4383-9CAB-A56AE7F82B97Q37916643-BF36E608-BF66-41A6-8D89-440C5830D034Q37960523-2036ECA9-AFAB-4EFF-9E8E-91AC6215F797Q38428967-5090D05D-B07A-436B-B52D-55C0A0B0E1DDQ38958979-80146A77-50C4-4EB2-9DDF-7ED0B748FE6EQ40403932-620CE7E7-1CB4-4E93-AF87-2D54C586C21CQ47615885-4AF929DA-833C-41E3-8616-BB20E450A9F2Q47840254-BB06DA51-B089-46F9-B1B2-946FA3EB1D37Q48351693-8AE88F28-146B-4856-9D33-ED38D4ED1B65Q50007004-EE832FB8-E960-4ACD-856D-48F3AB7A0A38Q50795169-B1FAD3FD-BFCB-4CDB-8FE7-04FFF353E5C7Q51944364-0CB96CA5-C2C1-4168-893E-7B28FAAF5624
P2860
Cigarette smoking in Parkinson's disease: influence on disease progression.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Cigarette smoking in Parkinson's disease: influence on disease progression.
@en
Cigarette smoking in Parkinson's disease: influence on disease progression.
@nl
type
label
Cigarette smoking in Parkinson's disease: influence on disease progression.
@en
Cigarette smoking in Parkinson's disease: influence on disease progression.
@nl
prefLabel
Cigarette smoking in Parkinson's disease: influence on disease progression.
@en
Cigarette smoking in Parkinson's disease: influence on disease progression.
@nl
P2093
P2860
P356
P1433
P1476
Cigarette smoking in Parkinson's disease: influence on disease progression.
@en
P2093
Jan P Larsen
Martin Kurz
Stein A Lie
P2860
P304
P356
10.1002/MDS.20117
P407
P50
P577
2004-09-01T00:00:00Z